Alpha Edison Backs Oxford Quantum Circuits Series C
Alpha Edison participated in the Series C for Oxford Quantum Circuits in June 2026, as the LA firm is reported to be raising a new $340M fund.
deep-tech — Venture Capital Articles & Research
Explore our latest articles on deep-tech — covering venture capital deals, fund activity, startup fundraising strategy, and investor research relevant to this topic.
Whether you're a founder building an investor target list, an analyst tracking deal flow, or an operator researching market trends, the articles below provide practical, up-to-date venture capital intelligence.
Why This Topic Matters in VC
- Deal flow signal: Funding activity and investor conviction in deep-tech
- Fundraising context: Which investors are active and what traction they expect
- Market timing: Sector momentum, valuation benchmarks, and competitive dynamics
Browse all deep-tech articles below, or use our VC directory to research active investors by stage and sector.
Related Articles (33 articles)
-
-
Compound Backs Orbital Materials $50M Series B for Industrial AI
Deep-tech firm Compound backed Orbital Materials’ $50M Series B, an AI engine for the physical economy and data-center hardware.
-
Cantos Backs Heaviside Industries $28M Series A in Defense Tech
Cantos backed Heaviside Industries’ $28M Series A (May 2026). That round is historical: the live mark is $600M after a $60M Series B on August 12, 2026.
-
NYC's University Startup Pipeline: Cornell Tech, Columbia, NYU, and Rockefeller
NYC's universities produce a meaningful slice of the city's startup pipeline. Here's how Cornell Tech, Columbia, NYU, and Rockefeller feed the ecosystem.
-
Lux Capital: The NYC Firm Underwriting Frontier Science and Deep Tech at $4B AUM
Lux Capital backs companies where science and engineering outpace convention — quantum, biotech, defense, robotics. Here's how the NYC firm plays 2026.
-
Two Sigma Ventures Leads Osmo $70M Series B in Digital Olfaction
Two Sigma Ventures led Osmo’s $70M Series B to scale digital olfaction, one of the firm’s final marquee rounds before its spinout into Deviation Capital.